POOR RESPONSE TO RIVAROXABAN IN A PATIENT WITH NEPHROTIC SYNDROME AND VENOUS THROMBOEMBOLISM

被引：0
|
作者：
Khine, Thin
Lee, Jaeine
Shakouri, Payam
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3921
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：6087A / 6088A
页数：2
相关论文
共 50 条
  • [41] Rivaroxaban for the treatment of venous thromboembolism in pediatric patients
    Cohen, Omri
    Levy-Mendelovich, Sarina
    Ageno, Walter
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (11) : 733 - 741
  • [42] Cerebral venous thrombosis in an adult patient with nephrotic syndrome
    Wei Luhua
    Liu Yang
    Huang Yining
    中华医学杂志（英文版）, 2014, (18) : 3354 - 3355
  • [43] Cerebral venous thrombosis in an adult patient with nephrotic syndrome
    Wei Luhua
    Liu Yang
    Huang Yining
    CHINESE MEDICAL JOURNAL, 2014, 127 (18) : 3354 - 3355
  • [44] Oral Rivaroxaban for Symptomatic Venous Thromboembolism REPLY
    Buller, Harry R.
    Lensing, Anthonie W. A.
    Prins, Martin H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12): : 1178 - 1178
  • [45] Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
    Bauersachs, Rupert
    Berkowitz, Scott D.
    Brenner, Benjamin
    Buller, Harry R.
    Decousus, Herve
    Gallus, Alex S.
    Lensing, Anthonie W.
    Misselwitz, Frank
    Prins, Martin H.
    Raskob, Gary E.
    Segers, Annelise
    Verhamme, Peter
    Wells, Phil
    Agnelli, Giancarlo
    Bounameaux, Henri
    Cohen, Alexander
    Davidson, Bruce L.
    Piovella, Franco
    Schellong, Sebastian
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26): : 2499 - 2510
  • [46] Statin use in patients with nephrotic syndrome is associated with risk reduction of venous thromboembolism
    Resh, M.
    Mahmoodi, B.
    Navis, G.
    Veeger, N.
    Lijfering, W.
    Van der Meer, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 736 - 736
  • [47] Infections Are Associated with Higher Risk of Venous Thromboembolism in Hospitalized Children with Nephrotic Syndrome
    Goldman, Jennifer
    Carpenter, Shannon L.
    Sherman, Ashley K.
    Selewski, David
    Kallash, Mahmoud
    Tran, Cheryl
    Seamon, Meredith
    Katsoufis, Chryso
    Ashoor, Isa
    Supe-Markovina, Katarina
    Hernandez, Joel D.
    Silva, Cynthia
    Gonzalez, Nilka De Jesus
    Vasylyeva, Tetyana
    Formeck, Cassandra
    Woll, Christopher
    Gbadegesin, Rasheed
    Geier, Pavel
    Devarajan, Prasad
    Smoyer, William E.
    Kerlin, Bryce A.
    Rheault, Michelle
    BLOOD, 2016, 128 (22)
  • [48] Risk factors for venous thromboembolism in patients with nephrotic syndrome: a retrospective cohort study
    Shinkawa, Kanna
    Yoshida, Satomi
    Seki, Tomotsugu
    Yanagita, Motoko
    Kawakami, Koji
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (07) : 1199 - 1206
  • [49] Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism
    Resh, Mohammad
    Mahmoodi, Bakhtawar K.
    Navis, Gerjan J.
    Veeger, Nic J. G. M.
    Lijfering, Willem M.
    THROMBOSIS RESEARCH, 2011, 127 (05) : 395 - 399
  • [50] Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism
    Arachchillage, D. R. J.
    Mackie, I. J.
    Efthymiou, M.
    Chitolie, A.
    Hunt, B. J.
    Isenberg, D. A.
    Khamashta, M.
    Machin, S. J.
    Cohen, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (11) : 2177 - 2186
12345